Cargando…
Fulminant and Non-fulminant Clinical COVID-19 Myocarditis in the New York City Area in 2020
BACKGROUND: COVID-19 myocarditis is becoming increasingly appreciated as a complication of COVID-19. There are significant hurdles to formal diagnosis with endomyocardial biopsy or cardiac MRI, whether by resource limitations, patient instability, or isolation precautions. Therefore, further explora...
Autores principales: | Wong, Christopher, Mansoor, Amtul, McGinn, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ubiquity Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916055/ https://www.ncbi.nlm.nih.gov/pubmed/35433282 http://dx.doi.org/10.5334/aogh.3583 |
Ejemplares similares
-
Early characteristics of fulminant myocarditis vs non-fulminant myocarditis: A meta-analysis
por: Wang, Zicheng, et al.
Publicado: (2019) -
Fulminant myocarditis in the time of coronavirus
por: Cuomo, Vittoria, et al.
Publicado: (2020) -
Fulminant myocarditis and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020) -
COVID-Induced Fulminant Myocarditis
por: Rodriguez Guerra, Miguel A, et al.
Publicado: (2022) -
Transient Myocarditis Associated with Fulminant Colitis
por: Williamson, J. M. L., et al.
Publicado: (2011)